Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10872710 | FEBS Letters | 2005 | 7 Pages |
Abstract
The structure of human cytosolic thymidine kinase in complex with its feedback inhibitor 2â²-deoxythymidine-5â²-triphosphate was determined. This structure is the first representative of the type II thymidine kinases found in several pathogens. The structure deviates strongly from the known structures of type I thymidine kinases such as the Herpes simplex enzyme. It contains a zinc-binding domain with four cysteines complexing a structural zinc ion. Interestingly, the backbone atoms of the type II enzyme bind thymine via hydrogen-bonds, in contrast to type I, where side chains are involved. This results in a specificity difference exploited for antiviral therapy. The presented structure will foster the development of new drugs and prodrugs for numerous therapeutic applications.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Markus S. Birringer, Michael T. Claus, Gerd Folkers, Daniel P. Kloer, Georg E. Schulz, Leonardo Scapozza,